BCL9-2 Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

BCL9-2 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 20 amino acid peptide near the amino terminus of human Bcl9L.

  Source: Synthetic

  (Accession #: NP_872363)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: BCL9L
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76542.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for BCL9-2 Antibody Blocking Peptide

• B-cell CLL/lymphoma 9-like protein
• B-cell CLL/lymphoma 9-like
• B-cell lymphoma 9-like protein
• Bcl92
• Bcl9-2
• BCL9-like protein
• DLNB11
• DLNB11BCL9-2
• nuclear co-factor of beta-catenin signalling
• Protein BCL9-2

Background

BCL9L - B-cell CLL/lymphoma 9-like

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: BCL9L